Are Wall Street Analysts Bullish on Quest Diagnostics Stock?
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 24 2025
0mins
Source: NASDAQ.COM
Company Performance: Quest Diagnostics (DGX) has outperformed the S&P 500 and SPDR S&P Health Care Services ETF over the past year, with a 35.9% increase in stock value compared to the broader market's 20.7% rise, driven by consistent demand, innovation, and strategic acquisitions.
Analyst Ratings and Expectations: Analysts maintain a "Moderate Buy" consensus on DGX stock, with an adjusted EPS forecast of $9.70 for fiscal 2025, and Mizuho Financial has raised its price target to $178, indicating potential upside from current levels.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MFG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MFG
Wall Street analysts forecast MFG stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 8.850
Low
38.88
Averages
38.88
High
38.88
Current: 8.850
Low
38.88
Averages
38.88
High
38.88
About MFG
Mizuho Financial Group Inc is a Japan-based company mainly engaged in the banking, trust banking, securities, and other financial services. The Company operates through five business segments: Retail & Business Corporations Company (RBC), Corporate & Investment Banking Company (CIBC), Global Corporate & Investment Banking Company (GCIBC), Global Markets Company (GMC), and Asset Management Company (AMC). The CIBC segment operates for clients of large corporate corporations, financial corporations and public corporations in Japan. The GCIBC segment operates for clients of overseas-affiliated Japanese companies and non-Japanese companies. The GMC segment is engaged in investment business in interest rates, equity, among others. The AMC segment is engaged in the development and provision of products that meet the asset management needs of clients from individuals to institutional investors.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Starbucks' Profit Recovery Progresses Slowly
- Sales Growth Recovery: Starbucks' 'Back to Starbucks' initiative has successfully increased customer traffic, leading to a resurgence in comparable-store sales, although profitability remains below historical levels, indicating early signs of recovery.
- Profitability Challenges: Analysts expect the adjusted operating margin for Q2 FY2026 to reach 8.3%, a modest increase from last year, yet still far below the mid-to-upper teens margins seen pre-pandemic, reflecting the difficulties in profit recovery.
- Increased Cost Pressures: The operating margin has risen from 27.4% of sales in FY2019 to 31.9% in FY2025 due to rising wages and operational costs, presenting significant challenges for the company in enhancing profitability.
- Cautious Future Outlook: Starbucks projects an operating margin range of 13.5% to 15% by FY2028, although this target has disappointed Wall Street expectations, highlighting skepticism about the company's ability to restore profitability.
See More
Analysis of AI Investment Trends
- Market Size Expectations: AI infrastructure spending is projected to reach approximately $700 billion by 2026, and despite investor concerns about peak spending, the underlying market opportunity remains significant, particularly as large tech companies report strong revenue growth.
- Nvidia's Strong Growth: Nvidia's revenue for fiscal 2026 is expected to surge 65% year-over-year to $215.9 billion, driven largely by aggressive data center investments, with CEO Jensen Huang forecasting a data center AI opportunity exceeding $1 trillion, reflecting robust demand for its products.
- Taiwan Semiconductor's Key Role: Taiwan Semiconductor's revenue rose 39% year-over-year to $35.9 billion in Q1 2026, showcasing its strong pricing power in high-performance computing and advanced nodes, with management expecting revenue growth above 30% in 2026.
- Microsoft's Steady Growth: Microsoft anticipates a 16.2% year-over-year revenue increase to $81.4 billion in Q3 2026, driven by its cloud platform and long-term contracts, highlighting its long-term potential and leadership position in the AI sector.
See More
Nvidia Leads AI Chip Market Amidst Strong Demand
- Market Dominance: Nvidia's revenue for fiscal 2026 reached $215.9 billion, a 65% year-over-year increase, primarily driven by aggressive investments from hyperscalers, underscoring its crucial role in global AI infrastructure development.
- Strong Growth Outlook: Taiwan Semiconductor Manufacturing reported a 39% year-over-year revenue increase to $35.9 billion in Q1 2026, with gross margin rising to 66.2%, and expects revenue growth above 30% year-over-year in 2026, highlighting its significance in AI demand.
- Custom Chip Demand: Broadcom anticipates a 47% year-over-year revenue growth to around $22 billion in Q2 2026, with AI semiconductor revenue projected to rise 140% to $10.7 billion, indicating its key role in building AI systems.
- Government Contract Support: Palantir's $10 billion contract with the U.S. military ensures long-term stable revenue, while its AI platform is rapidly gaining traction across various industries, enhancing its competitive position in the market.
See More
AI Investor Bullish on Microsoft and Broadcom Amid Market Turmoil
- AI Investment Strategy: An AI agent based on Anthropic's Claude models counterintuitively increased its positions in Microsoft and Broadcom, allocating 10% and 8% of the portfolio respectively, demonstrating high confidence in expected returns exceeding 20%, highlighting AI's unique advantage in risk assessment.
- Microsoft's Valuation Opportunity: Despite a 28% drop in Microsoft's stock price prior to the Iran ceasefire, Claude views its 20x forward P/E ratio as undervalued compared to the software sector average, indicating a market mispricing of its cloud platform, with expectations that growth from Azure and Copilot will make current valuation compression temporary.
- Broadcom's Market Dominance: Claude identifies Broadcom as the
See More
AI Agents Identify Microsoft and Broadcom as High-Conviction Buys Amid Market Volatility
- AI Investment Strategy: Anthropic's Claude model identified Microsoft and Broadcom as high-conviction buys following the Iran ceasefire announcement, leading to a surge in both stocks, showcasing AI's unique advantages in navigating market volatility.
- Microsoft Valuation Insight: Despite a 28% drop in Microsoft's stock price this year, Claude views its 20x forward P/E ratio as undervalued compared to the software sector average, indicating a market mispricing that could lead to significant future earnings recovery.
- Broadcom's Market Position: Claude allocated 10% of its portfolio to Broadcom, recognizing its 60%-80% share in the custom AI chip market, with projected orders reaching $100 billion by 2027, highlighting strong growth potential.
- Long-Term Growth Outlook: The AI model sees Microsoft and Broadcom as pivotal players in the next decade of AI development, and while the market remains cautious about semiconductor cyclical risks, Claude identifies structural growth inevitability.
See More
Medicare Payment Increase Boosts CVS Stock Recovery
- Impact of Medicare Policy: The CMS's finalized Medicare payment increase of nearly 2.5% significantly improves the profitability outlook for CVS and other healthcare stocks, leading to a stock price rebound compared to the previously proposed 0.09% increase.
- Upgraded Earnings Expectations: Analysts project CVS's earnings per share to reach between $7 and $7.20 in 2026, with the increase in Medicare payments likely enhancing CVS's profitability and boosting market confidence.
- Stock Valuation Potential: Currently trading at around 11 times forward earnings, CVS could see its stock price rise to $90 or $100 if it narrows the valuation gap with competitors like UnitedHealth Group, offering substantial investment returns.
- Stable Dividend Yield: With a forward dividend yield of 3.4%, CVS not only provides steady income but also attracts long-term investors, further supporting the upward momentum of its stock price.
See More
Starbucks' Profit Recovery Progresses Slowly
- Sales Growth Recovery: Starbucks' 'Back to Starbucks' initiative has successfully increased customer traffic, leading to a resurgence in comparable-store sales, although profitability remains below historical levels, indicating early signs of recovery.
- Profitability Challenges: Analysts expect the adjusted operating margin for Q2 FY2026 to reach 8.3%, a modest increase from last year, yet still far below the mid-to-upper teens margins seen pre-pandemic, reflecting the difficulties in profit recovery.
- Increased Cost Pressures: The operating margin has risen from 27.4% of sales in FY2019 to 31.9% in FY2025 due to rising wages and operational costs, presenting significant challenges for the company in enhancing profitability.
- Cautious Future Outlook: Starbucks projects an operating margin range of 13.5% to 15% by FY2028, although this target has disappointed Wall Street expectations, highlighting skepticism about the company's ability to restore profitability.
See More
Analysis of AI Investment Trends
- Market Size Expectations: AI infrastructure spending is projected to reach approximately $700 billion by 2026, and despite investor concerns about peak spending, the underlying market opportunity remains significant, particularly as large tech companies report strong revenue growth.
- Nvidia's Strong Growth: Nvidia's revenue for fiscal 2026 is expected to surge 65% year-over-year to $215.9 billion, driven largely by aggressive data center investments, with CEO Jensen Huang forecasting a data center AI opportunity exceeding $1 trillion, reflecting robust demand for its products.
- Taiwan Semiconductor's Key Role: Taiwan Semiconductor's revenue rose 39% year-over-year to $35.9 billion in Q1 2026, showcasing its strong pricing power in high-performance computing and advanced nodes, with management expecting revenue growth above 30% in 2026.
- Microsoft's Steady Growth: Microsoft anticipates a 16.2% year-over-year revenue increase to $81.4 billion in Q3 2026, driven by its cloud platform and long-term contracts, highlighting its long-term potential and leadership position in the AI sector.
See More
Nvidia Leads AI Chip Market Amidst Strong Demand
- Market Dominance: Nvidia's revenue for fiscal 2026 reached $215.9 billion, a 65% year-over-year increase, primarily driven by aggressive investments from hyperscalers, underscoring its crucial role in global AI infrastructure development.
- Strong Growth Outlook: Taiwan Semiconductor Manufacturing reported a 39% year-over-year revenue increase to $35.9 billion in Q1 2026, with gross margin rising to 66.2%, and expects revenue growth above 30% year-over-year in 2026, highlighting its significance in AI demand.
- Custom Chip Demand: Broadcom anticipates a 47% year-over-year revenue growth to around $22 billion in Q2 2026, with AI semiconductor revenue projected to rise 140% to $10.7 billion, indicating its key role in building AI systems.
- Government Contract Support: Palantir's $10 billion contract with the U.S. military ensures long-term stable revenue, while its AI platform is rapidly gaining traction across various industries, enhancing its competitive position in the market.
See More
AI Investor Bullish on Microsoft and Broadcom Amid Market Turmoil
- AI Investment Strategy: An AI agent based on Anthropic's Claude models counterintuitively increased its positions in Microsoft and Broadcom, allocating 10% and 8% of the portfolio respectively, demonstrating high confidence in expected returns exceeding 20%, highlighting AI's unique advantage in risk assessment.
- Microsoft's Valuation Opportunity: Despite a 28% drop in Microsoft's stock price prior to the Iran ceasefire, Claude views its 20x forward P/E ratio as undervalued compared to the software sector average, indicating a market mispricing of its cloud platform, with expectations that growth from Azure and Copilot will make current valuation compression temporary.
- Broadcom's Market Dominance: Claude identifies Broadcom as the
See More
AI Agents Identify Microsoft and Broadcom as High-Conviction Buys Amid Market Volatility
- AI Investment Strategy: Anthropic's Claude model identified Microsoft and Broadcom as high-conviction buys following the Iran ceasefire announcement, leading to a surge in both stocks, showcasing AI's unique advantages in navigating market volatility.
- Microsoft Valuation Insight: Despite a 28% drop in Microsoft's stock price this year, Claude views its 20x forward P/E ratio as undervalued compared to the software sector average, indicating a market mispricing that could lead to significant future earnings recovery.
- Broadcom's Market Position: Claude allocated 10% of its portfolio to Broadcom, recognizing its 60%-80% share in the custom AI chip market, with projected orders reaching $100 billion by 2027, highlighting strong growth potential.
- Long-Term Growth Outlook: The AI model sees Microsoft and Broadcom as pivotal players in the next decade of AI development, and while the market remains cautious about semiconductor cyclical risks, Claude identifies structural growth inevitability.
See More
Medicare Payment Increase Boosts CVS Stock Recovery
- Impact of Medicare Policy: The CMS's finalized Medicare payment increase of nearly 2.5% significantly improves the profitability outlook for CVS and other healthcare stocks, leading to a stock price rebound compared to the previously proposed 0.09% increase.
- Upgraded Earnings Expectations: Analysts project CVS's earnings per share to reach between $7 and $7.20 in 2026, with the increase in Medicare payments likely enhancing CVS's profitability and boosting market confidence.
- Stock Valuation Potential: Currently trading at around 11 times forward earnings, CVS could see its stock price rise to $90 or $100 if it narrows the valuation gap with competitors like UnitedHealth Group, offering substantial investment returns.
- Stable Dividend Yield: With a forward dividend yield of 3.4%, CVS not only provides steady income but also attracts long-term investors, further supporting the upward momentum of its stock price.
See More
